LIFETIME BRANDS, INC (LCUT)
Lifetime Brands, Inc. Reports Second Quarter 2026 Financial Results
BAUSCH HEALTH COMPANIES INC. (BHC)
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
TARSUS PHARMACEUTICALS, INC. (TARS)
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
Insmed Inc (INSM)
Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
Immunovant Inc (IMVT)
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
Evolent Health Inc (EVH)
Evolent Announces Second Quarter 2026 Results
Avalo Therapeutics Inc. (AVTX)
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
OCUGEN, INC. (OCGN)
Ocugen Provides Business Update with Second Quarter 2026 Financial Results
TARSUS PHARMACEUTICALS, INC. (TARS)
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
Immunocore Holdings plc (IMCR)
Immunocore reports second quarter financial results and provides a business update
Viridian Therapeutics Inc. (VRDN)
Viridian Therapeutics, Inc. - Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
SAFE PRO GROUP INC. (SPAI)
Safe Pro Group Receives $780,000 Purchase Order for Department of War Package of Edge AI-Powered Threat Mapping and Blue UAS Drones
PRECISION BIOSCIENCES INC (DTIL)
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
TARSUS PHARMACEUTICALS, INC. (TARS)
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)
Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results